In PMN-mediated ADCC against T-ALL cell lines, significant cytotoxicity was seen with the IgA2 isotype of daratumumab when it was combined with the CD47 blocking antibody (Figure 3A, lower panel). The gene discussed is CD47; the disease is acute lymphoblastic leukemia.